bullish
JD Health (6618.HK) 2021 Results - The Logic and the Outlook
383 Views06 Apr 2022 00:55
The service revenue has larger potential and is complementary to product revenue.Due to the essence of medical attributes,even if JD Health's online healthcare services fails, it could still stand out
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »- JD Health (6618.HK) 23Q3 - Performance Decline Is Inevitable, but There Is Upside Room for Valuation
- [JD Health (6618 HK, BUY, TP HK$52) TP Change]: A COVID Hiccup but Environment Is Turning Positive
- JD Health (6618.HK) 23H1 - The Beautiful Story Is Over; It's Time to Face Reality
- [JD Health (6618 HK, BUY, TP HK$65) TP Change]: Benefit of Alternative Channel Starts to Show
- JD Health 1H2023: Reports Operating Profits; Margin Upside Is Very Limited
Trending Collections
More »Trending Insights
More »Top Unpaywalled Insights
More »- [IO Technicals 2025/31] Muted Policy Support and Soft Demand Weigh on IO Prices
- Bond Market Monitor: Thailand Unsmiled
- Indian Banking’s Longest-Serving, Highest-Paid HR-Head Quits IndusInd Bank
- [IO Technicals 2025/30] Iron Ore Rally Cools on Supply Surge, but Policy Hopes Keep Prices Afloat
- New Barbarians Podcast | Episode #029 | Recap & Reset: Macro Shifts, Ethereum's Spike, MicroStrat...
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Pre-IPO Beijing Yuanxin Technology Group - Conservative About the Outlook17 Jun 2022
- China Healthcare Weekly (Apr.8)-Surgical Robots Pricing Rules,America COMPETES Act,COVID-19 Sequelae10 Apr 2022
- Medlive Technology (2192.HK) - The Logic Has Shaken07 Apr 2022
- JD Health (6618.HK) 2021 Results - The Logic and the Outlook06 Apr 2022
- Innovent Biologics Inc (1801.HK) - Capable of Surviving “this Winter”03 Apr 2022
- Ping An Good Doctor (1833.HK) - A Vicious Cycle?30 Aug 2021
- JD Health (6618.HK) - Opportunities Coexist with Challenges15 Dec 2020
x